卵巢清细胞癌的免疫疗法时代:当前的证据和未来的前景
Anna Passarelli1, Sabrina Chiara Cecere1, Jole Ventriglia1
1Department of Urology and Gynecology, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G. Pascale, Naples, Italy.
Frontiers in immunology
|December 12, 2025
概括
卵巢清细胞癌 (OCCC) 是一种具有不良预后的侵袭性癌症. 针对其独特的生物学和免疫抑制瘤微环境的新型疗法显示出更好的患者结果的希望.
科学领域:
- 妇科瘤学 妇科瘤学
- 癌症生物学 癌症生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 卵巢清细胞癌 (OCCC) 是一种罕见的,具有不良预后的侵袭性亚型.
- OCCC与子宫内膜异位症有关,其特征是特定的遗传突变 (ARID1A,PIK3CA) 和途径过活化 (PI3K/Akt/mTOR).
- OCCC瘤微环境具有免疫抑制作用,促进免疫逃避和化学抵抗.
研究的目的:
- 审查OCCC的分子基础.
- 讨论治疗挑战和新兴策略.
- 突出针对OCCC独特的遗传和免疫特征的潜力.
主要方法:
- 对OCCC分子特征的文献综述.
- 对OCCC疗法的当前和初步临床试验数据的分析.
- 探索新的治疗点和组合策略.
主要成果:
- OCCC表现出独特的生物学驱动的扩散,血管新生和免疫逃避.
- 免疫检查点抑制剂 (ICI) 在OCCC中显示出有前途的子组敏感性.
- 与ICI一起针对多个途径 (VEGF,IL-6,HIF-1α,HDAC6) 的组合疗法正在研究中.
结论:
- OCCC需要创新的,多目标的治疗策略.
- 个性化,生物标记驱动的方法对于OCCC管理至关重要.
- 了解基因-免疫学相互作用是开发有效OCCC治疗的关键.
更多相关视频
07:59Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1
Published on: December 5, 2020
2.9K
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
3.1K
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Vaccines
929
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
929
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
